Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer

Journal of the National Cancer Institute

Volumn 104, Issue 13, 2012, Pages 990-1004

  Hart, Stacey L ^a   Hoyt, Michael A ^b   Diefenbach, Michael ^c   Anderson, Derek R ^d   Kilbourn, Kristin M ^e   Craft, Lynette L ^f   Steel, Jennifer L ^g   Cuijpers, Pim ^h   Mohr, David C ^f   Berendsen, Mark ^f   Spring, Bonnie ^f   Stanton, Annette L ⁱ  

^a RYERSON UNIVERSITY   (Canada)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; FLUOXETINE; MIANSERIN; PAROXETINE; PLACEBO;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; FOLLOW UP; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; SYSTEMATIC REVIEW;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; HUMANS; NEOPLASMS; PROBLEM SOLVING; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84863895261     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs256     Document Type: Article

References (103)

1. Moyer A, Sohl SJ, Knapp-Oliver SK, et al. Characteristics and methodological quality of 25 years of research investigating psychosocial interventions for cancer patients. Cancer Treat Rev. 2009;35(5):475-484.
2. Polsky D, Doshi JA, Marcus S, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005;165(11):1260-1266.
3. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliativecare settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174.
4. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
5. Himelhoch S, Weller WE, Wu AW, et al. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care. 2004;42(6):512-521.
6. Steiner J, Cavender T, Nowels C, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psycho-oncology. 2008;17(2):138-147.
7. Miller M, Mogun H, Azrael D, et al. Cancer and the risk of suicide in older Americans. J Clin Oncol. 2008;26(29):4720-4724.
8. Misono S, Weiss NS, Fann JR, et al. Incidence of suicide in persons with cancer. J Clin Oncol. 2008;26(29):4731-4738.
9. Walker J, Waters RA, Murray G, et al. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol. 2008;26(29):4725-4730.
10. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366(14):1310-1318.
11. Brown KW, Levy AR, Rosberger Z, et al. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003;65(4):636-643.
12. Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2004;52(1):106-111.
13. Mykletun A, Bjerkeset O, Dewey M, et al. Anxiety, depression, and causespecific mortality: the HUNT study. Psychosom Med. 2007;69(4):323-331.
14. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28(5):396-402.
15. Pinquart M, Duberstein PR. Depression and cancer mortality: a metaanalysis. Psychol Med. 2010;40(11):1797-1810.
16. Satin JR, Linden W, Phillips MF. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349-5361.
17. Steel JL, Geller DA, Gamblin C, et al. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007;25(17):2397-2405.
18. Akechi T, Okuyama T, Onishi J, et al. Psychotherapy for depression among incurable cancer patients (Review). Cochrane Database Syst Rev. 2008;16(2):Art. No.CD0055372008.
19. Andersen BL. Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol. 2002;70(3):590-610.
20. Andrykowski MA, Manne SL. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. Ann Behav Med. 2006;32(2):93-97.
21. Barsevick AM, Sweeney C, Haney E, et al. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum. 2002;29(1):73-84.
22. Coyne JC, Lepore SJ, Palmer SC. Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks. Ann Behav Med. 2006;32(2):104-110.
23. Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum. 1995;22(9):1369-1381.
24. Jacobsen PB, Donovan KA, Swaine ZN, et al. Management of anxiety and depression in adult cancer patients: toward an evidence-based approach. In: Chang AE, Ganz PA, Hayes DF, et al., eds. Oncology: An Evidence-Based Approach. Philadelphia, PA: Springer; 2006:1552-1579.
25. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 1995;14(2):101-108.
26. Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst. 2002;94(8):558-584.
27. Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006;36(1):3-34.
28. Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta-analysis of 37 published controlled outcome studies. Patient Educ Couns. 2003;50(2):179-186.
29. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer. 1999;80(11):1770-1780.
30. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006;94(3):372-390.
31. Schneider S, Moyer A, Knapp-Oliver S, et al. Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med. 2010;33(1):1-14.
32. Heron-Speirs HA, Harvey ST, Baken DM. Moderators of psycho-oncology therapy effectiveness: addressing design variable confounds in metaanalysis. Clin Psychol Sci Pract. 2012;19(1):49-71.
33. Rodin G, Lloyd N, Katz M, et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007;15(2):123-136.
34. McQuellon RP, Wells M, Hoffman S, et al. Reducing distress in cancer patients with an orientation program. Psycho-oncology. 1998;7(3):207-217.
35. Kissane DW, Bloch S, Smith GC, et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomized controlled trial. Psycho-oncology. 2003;12(6):532-546.
36. Sharpe M, Strong V, Allen K, et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer. 2004;90(2):310-313.
37. Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2203-2208.
38. Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol. 2007;25(5):532-539.
39. Goerling U, Foerg A, Sander S, et al. The impact of short-term psychooncological interventions on the psychological outcome of cancer patients of a surgical-oncology department-a randomized controlled study. Eur J Cancer. 2011;47(13):2009-2014.
40. Stockler MR, O'Connell R, Nowak AK, et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol. 2007;8(7):603-612.
41. Kroenke K, Theobald D, Wu J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010;304(2):163-171.
42. Holland JC, Morrow GR, Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol. 1991;9(6):1004-1011.
43. Holland JC, Romano SJ, Heiligenstein JH, et al. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology. 1998;7(4):291-300.
44. Moorey S, Greer S, Bliss J, et al. A comparison of adjuvant psychological therapy and supportive counseling in patients with cancer. Psycho-oncology. 1998;7(3):218-228.
45. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat. 2001;70(1):1-10.
46. Razavi D, Kormoss N, Collard A, et al. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Res. 1999;27(6):264-272.
47. Hopko DR, Armento MEA, Robertson SMC, et al. Brief behavioral activation and problem-solving therapy for depressed breast cancer patients: randomized trial. J Consult Clin Psychol. 2011;79(6):834-849.
48. Rodríguez Vega B, Palao A, Torres G, et al. Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial. Psycho-oncology. 2011;20(9):943-952.
49. Feng Y, Wang X, Li S, et al. Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality. J Tradit Chin Med. 2011;31(3):199-202.
50. Centre for Evidence-Based Physiotherapy. PEDro Scale. Sydney, Australia: Centre for Evidence-Based Physiotherapy; 2009. http://www. pedro.org.au. Accessed April 20, 2012.
51. Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443-451.
52. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Metaanalysis Version 2. Englewood, NJ: Biostat; 2005.
53. Hedges LV. Distribution theory for Glass's estimator of effect size and related estimators. J Educ Stat. 1981;6(2):107-128.
54. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
55. Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994:231-244.
56. Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Newbury Park, CA: Sage; 2002.
57. Hunter JE, Schmidt FL. Methods of Meta-Analysis: Correcting Error and Bias in Research Findings. 2nd ed. Thousand Oaks, CA: Sage Publications; 2004.
58. Costa D, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand. 1985;72(suppl 320):85-92.
59. Evans RL, Connis RT. Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Public Health Rep. 1995;110(3):306-311.
60. Razavi D, Allilaire JF, Smith M, et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand. 1996;94(3):205-210.
61. Savard J, Simard S, Giguere I, et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care. 2006;4(3):219-237.
62. Musselman DL, Somerset WI, Guo Y, et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry. 2006;67(2):288-296.
63. Nezu AM, Nezu CM, Felgoise SH, et al. Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J Consult Clin Psychol. 2003;71(6):1036-1048.
64. Hesser H, Weise C, Rief W, Andersson G. The effect of waiting: a metaanalysis of wait-list control groups in trials for tinnitus distress. J Psychosom Res. 2011;70(4):378-384.
65. Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods. 1998;3(4):486-504.
66. Lipsey MW, Wilson DB. Practical Meta-Analysis. Applied Social Research Methods Series (vol. 49). Thousand Oaks, CA: Sage Publications; 2001.
67. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007;335(7626):914-916.
68. Orsini N, Higgins J, Bottai M, et al. Heterogi: Stata module to quantify heterogeneity in a meta-analysis, revised 2006-01-25 [computer program]. Statistical Software Components S449201. Boston, MA: Boston College Department of Economics; 2005. http://EconPapers.repec.org/software/bocbocode/s449201.htm. Accessed April 20, 2012.
69. Duval SJ, Tweedie RL. Trim and fill: a simple funnel plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
70. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315(7109):629-634.
71. Fisch MJ, Loehrer PJ, Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol. 2003;21(10):1937-1943.
72. Dwight-Johnson M, Ell K, Lee P-J. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosomatics. 2005;46(3):224-232.
73. Ell K, Xie B, Quon B, et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol. 2008;26(10):4488-4496.
74. Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet. 2008;372(9632):40-48.
75. Ell K, Xie B, Kapetanovic S, et al. One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer. Psychiatr Serv. 2011;62(2):162-170.
76. van Heeringen K, Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry. 1996;169(4):440-443.
77. Greer S, Moorey S, Baruch JD, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J. 1992;304(6828):675-680.
78. Moorey S, Greer S, Watson M, et al. Adjuvant psychological therapy for patients with cancer: outcome at one year. Psycho-oncology. 1994;3(1):39-46.
79. Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat. 2008;112(1):197-201.
80. Cuijpers P, van Straten A, Warmerdam L, et al. Characteristics of effective psychological treatments of depression: a meta-regression analysis. Psychother Res. 2008;18(2):225-236.
81. van Straten A, Geraedts A, Verdonch-de Leeuw I, et al. Psychological treatment of depressive symptoms in patients with medical disorders: a metaanalysis. J Psychosom Res. 2010;69(1):23-32.
82. Beltman MW, Voshaar RCO, Speckens AE. Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry. 2010;197(1):11-19.
83. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
84. Bower P, Gilbody S, Richards D, et al. Collaborative care for depression in primary care: making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry. 2006;189(6):484-493.
85. Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-2321.
86. Ell K, Aranda MP, Xie B, et al. Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials. Am J Geriatr Psychiatry. 2010;18(6):520-530.
87. Tolin DF. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clin Psychol Rev. 2010;30(6):710-720.
88. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31.
89. Speilmans GI, Berman MI, Usital AN. Psychotherapy versus second-generation antidepressants in the treatment of depression: a meta analysis. J Nerv Ment Dis. 2011;199(3):142-149.
90. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology-Distress Management (Version 1) [Electronic data type]. 2007. http://www.nccn.org/professionals/physician-gls/PDF/distress.pdf. Accessed April 20, 2012.
91. Institute of Medicine. Cancer Care for the Whole Patient: Meeting Psychosocial Needs. Board on Health Care Services. Washington, DC: The National Academic Press; 2007.
92. Carlson LE, Bultz BD. Cancer distress screening: needs, methods and models. J Psychosom Res. 2003;55(5):403-409.
93. Kruijver IP, Garssen B, Visser AP, et al. Signalising psychosocial problems in cancer care: the structural use of a short psychosocial checklist during medical or nursing visits. Patient Educ Couns. 2006;62(2):163-177.
94. Velikova G. Patient benefits from psychosocial care: screening for distress and models of care. J Clin Oncol. 2010;28(33):4871-4873.
95. Carlson LE, Groff SL, Maciejewski O, et al. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol. 2010;28(33):4884-4891.
96. Palmer S, van Scheppingen C, Coyne JC. Clinical trial did not demonstrate benefits of screening patients with cancer for distress. J Clin Oncol. 2011;29(10):e277-e278.
97. van Scheppingen C, Schroevers MJ, Smink A, et al. Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology. 2011;20(6):655-663.
98. Meijer A, Roseman M, Milette K, et al. Depression screening and patient outcomes in cancer: a systematic review. PLoS One. 2011;6(11):e27181. doi:10.1371/journal.pone.00278181.
99. Walker J, Cassidy J, Sharpe M, et al. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients. Trials. 2009;10(18). doi:10.1186/1745-6215-10-18.
100. Walker J, Cassidy J, Sharpe M, et al. The third Symptom Management Research Trial in Oncology (SMaRT Oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (Depression Care for People with Lung Cancer) to usual care, compared to usual care alone in patients with lung cancer. Trials. 2009;10(92). doi:10.1186/1745-6215-10-92.
101. Zautra AJ, Davis MC, Reich JW, et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol. 2008;76(3):408-421.
102. Dunn LB, Cooper BA, Neuhaus J, et al. Identification of distinct depressive symptoms trajectories in women following surgery for breast cancer. Health Psychol. 2011;30(6):683-692.
103. Henselmans I, Helgeson VS, Seltman H, et al. Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol. 2010;29(2):160-168.